Tests conducted by an online pharmacy has revealed high levels of NMDA in the diabetes drug metformin, prompting the company to press for a recall.
List view / Grid view
Filter the results
The EMA has released an update on nitrosamines in drugs, saying that work is continuing to prevent and manage these impurities.
The EMA has announced that metformin tablets from outside the EU do not contain unacceptable levels of NDMA impurities and EU metformin is not affected.
The FDA has released a statement on the investigations into the presence of nitrosamines in some drugs; highlighting that there are currently no recalls of metformin within the US.
Acidosis related to use of metformin seen only in those with severely decreased kidney function...
The oral diabetes medication metformin seems to reduce the chance of a late miscarriage and premature birth among women with polycystic ovary syndrome...
When women take the common diabetes medication metformin during pregnancy, it may put their children at increased risk of having obesity...